Teva and Alcobra to begin Phase III testing of non-stimulant ADHD drug in 2012
This article was originally published in Scrip
Executive Summary
Teva Pharmaceutical Industries and Alcobra hope to begin Phase III trials of the non-stimulant drug, MG01CI, in adults next year after reporting successful top-line results from a Phase II study of in adults with attention deficit hyperactivity disorder (ADHD). The companies said that paediatric trials would come later on.